Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 522 of 6351
-
New device aims to clear leg artery clots without major surgery
Disease control Recruiting nowThis study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
Sponsor: Inari Medical • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
MRNA vaccine aims to prevent shingles in older adults
Vaccine Recruiting nowThis clinical trial included two parts, Part A and Part B. The goal of Part A is to evaluate the safety and preliminary immunogenicity of the lyophilized herpes zoster virus mRNA vaccine (HZ mRNA vaccine) in healthy populations aged 40 years and older. The goal of Part B is to se…
Phase 1/2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 09:04 UTC
-
New hope for medium vessel stroke? trial tests direct Clot-Busting drug
Disease control Recruiting nowAcute ischemic stroke (AIS) due to medium vessel occlusion (MeVO) or severe stenosis poses a significant clinical challenge. Recent large randomized controlled trials, DISTAL and ESCAPE-MeVO, demonstrated no significant benefit of endovascular therapy in patients with MeVO. Altho…
Sponsor: The Second Hospital of Anhui Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New transplant combo aims to boost survival in blood cancer patients
Disease control Recruiting nowThe Flu-TBI 800 trial is a prospective, single-arm, multicenter, interventional phase 2 study to evaluate whether fludarabine plus intermediate-dose total body irradiation (TBI 800 cGy) with post-transplant cyclophosphamide (PTCy) (experimental regimen) improves the 1-year surviv…
Phase 2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
AI and MRI join forces to decode breast Cancer's hidden secrets
Knowledge-focused OngoingLuminal breast cancer is characterized by marked heterogeneity, resulting in diverse treatment responses and long-term outcomes. This project aims to integrate MRI and multiomics data to achieve non-invasive molecular typing and precise response prediction. By linking imaging phe…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Cord stem cells aim to tame muscle disease and cut steroid use
Disease control Recruiting nowThe goal of this clinical trial is to learn about how an umbilical cord lining-derived stem cell (ULSC) product performs when treating Dermatomyositis/Polymyositis (DM/PM), also known as idiopathic inflammatory myopathy (IIM) in adults. It will assess safety and efficacy in relie…
Phase 2/3 • Sponsor: Restem, LLC. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New lung cancer combo aims to beat current standard
Disease control Recruiting nowThis study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembrolizumab with chemotherapy) for adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that is eith…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Experimental CAR-T therapy targets tough childhood leukemia
Disease control CancelledA study to evaluate the safety and preliminary efficacy of CLL-1-targeted CAR-T cell therapy in children aged 3 to 18 years with relapsed or refractory acute myeloid leukemia (r/r AML).
Early phase 1 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a blood pressure cuff save organs during heart surgery?
Disease control Recruiting nowThe goal of this clinical trial is to learn if a technique called remote ischemic preconditioning (RIPC) helps protect organs during emergency surgery for acute type A aortic dissection (ATAAD). The main questions it aims to answer are: Does RIPC reduce the risk of major complic…
Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Brain vein stent could ease pressure for IIH patients
Disease control Recruiting nowThis study is aimed at patients suffering from long term intracranial hypertension (caracterized by visual loss, chronic headache and/or tinnitus), receiving acetazolamide for more than 1 year, having inadequate response to treatment (untolerable side effects or insufficient effi…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could injecting immunotherapy into lymph nodes boost cervical cancer treatment?
Disease control Recruiting nowWe aim to determine feasibility, safety and efficacy of TDLN-targeted immune checkpoint inhibition in different doses (nivolumab) in patients with cervical cancer.
Phase 1 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Breathing workouts may sharpen young minds and strengthen a key muscle
Disease control CompletedLow skeletal muscle mass during young adulthood may impair diaphragm function, cognition, sleep, and psychological well-being. Inspiratory muscle training (IMT) has been shown to improve respiratory muscle performance; however, it remains unclear whether different IMT intensities…
Sponsor: Hacettepe University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New shot targets lymphoma without chemo
Disease control Recruiting nowThis is a multi-center, open-label, interventional clinical trial designed to evaluate the efficacy and safety of subcutaneous (SC) Mosunetuzumab as a first-line immunotherapy in patients with low tumor burden follicular lymphoma (LTB-FL), defined by the absence of GELF criteria.
Phase 2 • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New oral pill aims to tackle weight loss without diabetes
Disease control CompletedThis is a phase II, multicenter, randomized, double-blind, placebo-controlled clinical trial to preliminarily evaluate the efficacy, safety, and PK of MWN109 tablets administered orally once daily in non-diabetic participants with overweight or obesity. Approximately 240 partici…
Phase 2 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug showdown: can nipocalimab beat efgartigimod for muscle weakness?
Disease control Recruiting nowThe purpose of this study is to assess how well nipocalimab works when compared to efgartigimod in participants with generalized myasthenia gravis (a condition in which body's immune system mistakenly attacks and damages the connection between nerves and muscles causing muscle we…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Engineered immune cells take on rare sarcoma in early trial
Disease control Recruiting nowThe purpose of this study is to verify the safety and the efficacy of TBI-1301 for NY-ESO-1 expressing synovial sarcoma when administered following cyclophosphamide/fludarabine pre-treatment.
Phase 3 • Sponsor: Takara Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Promising new drug targets seizures in rare GRIN disorder
Disease control Recruiting nowThe Phase 3 portion of Study RAD-GRIN-101 is a multinational, multicenter, randomized, double-blind, placebo-controlled trial followed by an open-label extension to evaluate the efficacy and safety of radiprodil in participants with GRIN-related neurodevelopmental disorder (GRIN-…
Phase 3 • Sponsor: GRIN Therapeutics, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for advanced breast cancer: drug combo aims to halt tumor growth
Disease control Not yet recruitingThis study aims to evaluate the efficacy of Entinostat combined with Fulvestrant in HR+/HER2- advanced breast cancer patients with recurrence/progression after endocrine therapy (primary endpoint: progression-free survival \[PFS\]), and explore the correlation between peripheral …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Brain cell transplant trial offers hope for rare Parkinson's-Like disease
Disease control Recruiting nowThis clinical trial is designed to evaluate the safety, tolerability and preliminary efficacy of a single injection of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in patients with Multiple System Atrophy.
Phase 1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Magic mushroom compound meets therapy in new depression trial
Symptom relief Recruiting nowThe primary objectives of this clinical investigation are to (1) determine the acceptability and feasibility of joining psilocybin-assisted therapy with cognitive-behavioral therapy (PA-CBT) for patients with depression, (2) optimize CBT to most effectively integrate the psilocyb…
Phase 1/2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC